SOX9 and squamous cell carcinoma: For their part, SOX2 and SOX9 are stem factors that play an important role in the acquired resistance of squamous cell carcinoma (SCC) to cisplatin: the detailed mechanism of this feature is the switch from SOX2+ to SOX9+ mediated by SE remodeling [120].